Nick Pizzie, Chief Financial Officer at Axsome Therapeutics, Inc. (AXSM), bought 31,000 shares at $3.10 ($96K) on 2018-06-19, disclosed to the SEC on 2018-06-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.05 | 400 | $1K | 1.3% |
| 2 | $3.10 | 30,600 | $95K | 98.7% |
| Total | $3.10 avg | 31,000 | $96K | 100% |
| Filing → |
| AXSM | SELL | 2025-02-14 | $3.5M | — | Filing → |
| AXSM | BUY | 2021-11-22 | $34K | — | Filing → |
| AXSM | BUY | 2020-06-30 | $119K | — | Filing → |